PALATIN TECHNOLOGIES, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PALATIN TECHNOLOGIES, INC. (PTN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.58 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-05-13
- PALATIN TECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 8.58M shares, a 2315.64% increase year-over-year.
- PALATIN TECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-12-31 was 8.59M shares, a 3189.79% increase year-over-year.
- PALATIN TECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 354.98K shares, a 95.83% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-12-31 was 261.19K shares, a 96.04% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 828.98K shares, a 267.53% increase from fiscal 2024.
- PALATIN TECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 225.55K shares, a 94.58% decline from fiscal 2023.
- PALATIN TECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 4.16M shares, a 45.91% increase from fiscal 2022.
- PALATIN TECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 2.85M shares, a 72.78% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 8.58M shares 10-Q · filed 2026-05-13 | 8.58M shares 10-Q · filed 2026-05-13 | ||||||
| 2025-12-31 | 8.59M shares 10-Q · filed 2026-02-17 | 8.59M shares 10-Q · filed 2026-02-17 | ||||||
| 2025-06-30 | 828.98K shares 10-K · filed 2025-09-23 | |||||||
| 2025-03-31 | 354.98K shares 10-Q · filed 2026-05-13 | 17.75M shares 10-Q · filed 2025-05-14 | 354.98K shares 10-Q · filed 2026-05-13 | 17.75M shares 10-Q · filed 2025-05-14 | ||||
| 2024-12-31 | 261.19K shares 10-Q · filed 2026-02-17 | 13.06M shares 10-Q · filed 2025-02-13 | 261.19K shares 10-Q · filed 2026-02-17 | 13.06M shares 10-Q · filed 2025-02-13 | ||||
| 2024-09-30 | 222.12K shares 10-Q · filed 2025-11-14 | 11.11M shares 10-Q · filed 2024-11-14 | ||||||
| 2024-06-30 | 225.55K shares 10-K · filed 2025-09-23 | 11.13M shares 10-K · filed 2024-09-30 | ||||||
| 2024-03-31 | 8.52M shares 10-Q · filed 2025-05-14 | 8.52M shares 10-Q · filed 2025-05-14 | 3.43M shares 10-Q · filed 2024-05-15 | |||||
| 2023-12-31 | 6.60M shares 10-Q · filed 2025-02-13 | 6.60M shares 10-Q · filed 2025-02-13 | ||||||
| 2023-09-30 | 4.52M shares 10-Q · filed 2024-11-14 | |||||||
| 2023-06-30 | 4.16M shares 10-K · filed 2024-09-30 | |||||||
| 2023-03-31 | 3.43M shares 10-Q · filed 2023-05-15 | 3.43M shares 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | 3.43M shares 10-Q · filed 2024-02-14 | 1.11M shares 10-Q · filed 2023-02-14 | ||||||
| 2022-09-30 | 2.83M shares 10-Q · filed 2023-11-14 | |||||||
| 2022-06-30 | 2.85M shares 10-K · filed 2023-09-28 | |||||||
| 2022-03-31 | 1.11M shares 10-Q · filed 2023-05-15 | 27.69M shares 10-Q · filed 2022-05-16 | 1.11M shares 10-Q · filed 2023-05-15 | 37.34M shares 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | 27.83M shares 10-Q · filed 2022-02-14 | 37.21M shares 10-Q · filed 2022-02-14 | ||||||
| 2021-09-30 | 1.32M shares 10-Q · filed 2022-11-14 | 32.93M shares 10-Q · filed 2021-11-15 | ||||||
| 2021-06-30 | 1.65M shares 10-K · filed 2022-09-22 | 41.26M shares 10-K · filed 2021-09-28 | ||||||
| 2021-03-31 | 27.69M shares 10-Q · filed 2022-05-16 | 37.34M shares 10-Q · filed 2021-05-14 | 37.34M shares 10-Q · filed 2022-05-16 | |||||
| 2020-12-31 | 27.83M shares 10-Q · filed 2022-02-14 | 37.21M shares 10-Q · filed 2021-02-16 | 37.21M shares 10-Q · filed 2022-02-14 | |||||
| 2020-09-30 | 38.53M shares 10-Q · filed 2021-11-15 | |||||||
| 2020-06-30 | 40.89M shares 10-K · filed 2021-09-28 | |||||||
| 2020-03-31 | 33.17M shares 10-Q · filed 2021-05-14 | 33.17M shares 10-Q · filed 2021-05-14 | ||||||
| 2019-12-31 | 33.14M shares 10-Q · filed 2021-02-16 | 33.14M shares 10-Q · filed 2021-02-16 | ||||||
| 2019-09-30 | 37.50M shares 10-Q · filed 2020-11-16 | |||||||
| 2019-06-30 | 6.13M shares 10-K · filed 2020-09-25 | |||||||
| 2019-03-31 | 40.82M shares 10-Q · filed 2020-05-11 | 40.82M shares 10-Q · filed 2020-05-11 | ||||||
| 2018-12-31 | 40.85M shares 10-Q · filed 2020-02-10 | 40.85M shares 10-Q · filed 2020-02-10 | ||||||
| 2018-09-30 | 41.45M shares 10-Q · filed 2019-11-12 | |||||||
| 2018-06-30 | 5.20M shares 10-K · filed 2020-09-25 | |||||||
| 2016-12-31 | 57.17M shares 10-Q · filed 2017-02-10 | |||||||
| 2016-09-30 | 44.48M shares 10-Q · filed 2016-11-14 | |||||||
| 2016-03-31 | 32.45M shares 10-Q · filed 2016-05-16 | |||||||
| 2015-12-31 | 34.90M shares 10-Q · filed 2017-02-10 | |||||||
| 2015-09-30 | 32.91M shares 10-Q · filed 2016-11-14 | |||||||
| 2015-03-31 | 29.21M shares 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |